SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending after its ANKTIVA bladder cancer treatment received European Commission authorization, significantly expanding its global market. This news, combined with high short interest, is igniting community speculation about a massive short squeeze and increasing anticipation for further global approvals.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending after its recent earnings showed a significant EPS beat attributed largely to non-cash tax benefits, overshadowing an Adjusted EBITDA miss and fueling community concerns about "accounting magic" and opaque related-party dealings.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

DoorDash rallied significantly after-hours following its latest earnings, which highlighted robust order growth and an optimistic marketplace outlook despite some estimate misses; this unexpected surge has ignited a fierce debate among investors, with many calling for a short squeeze against those who view the stock as overvalued.

Etsy, Inc. engages in the operation of an online marketplace. It offers handmade products such as shoes, clothing, bags, and accessories. It operates through the following segments: Etsy, Reverb, and Depop. The company was founded in 2005 and is headquartered in New York, NY.

Etsy Inc

Etsy is trending amid news of its Depop fashion marketplace sale to eBay for a substantial cash infusion, which the community is debating as a strategic refocus or a loss. Simultaneously, its new partnership with OpenAI for instant checkout via ChatGPT is generating mixed reactions on whether it will revolutionize the platform's sales or if its impact is overblown.

Clearwater Analytics Holdings, Inc. engages in the provision of web-based investment portfolio accounting, reporting, and reconciliation services. It operates through the United States and Rest of World geographical segments. Its products include automated data aggregation and validation, investment accounting, integrated reporting tools, a user-friendly solution, and business-specific tools. The company was founded in 2004 and is headquartered in Boise, ID.

Clearwater Analytics Holdings Inc - Ordinary Shares Class A

Clearwater Analytics is trending due to its announced acquisition for $24.55 per share by a private equity consortium; however, shareholders are actively debating if the offer undervalues the company given its strong growth and activist investor involvement. The community is focused on the ongoing go-shop period, fueling hopes for a higher bid.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

Cosmos (ATOM) is trending due to significant community discussions around its proposed tokenomics redesign, aiming to transition from an inflationary model to a revenue-based one. This, coupled with recent ETF filings incorporating staking, is fueling optimism about its future as the "Internet of Blockchains" and its potential for substantial price appreciation.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending as its acquisition of Shackleton Finance is seen as a strategic pivot to secure non-dilutive financing for massive AI infrastructure projects, a move bulls believe will unlock institutional capital and transform the company. However, the community remains divided, with many long-term holders expressing frustration over persistent price suppression and eagerly awaiting upcoming earnings for clarity and a potential turning point.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidental Petroleum is trending after reporting a strong quarterly earnings beat and completing the sale of its chemical business to Berkshire Hathaway, which substantially strengthened its balance sheet. The community is actively discussing these fundamental improvements and the ongoing geopolitical tensions impacting global oil supply as potential tailwinds for the energy sector.

B2Gold Corp. is an exploration company, which engages in the acquisition and development of mineral properties. It operates through the following segments: Fekola Mine, Fekola Regional, Masbate Mine, Otjikoto Mine, Goose Project, Other Mineral Properties, and Corporate and Other. The Fekola Regional segment consists of Bantako North, Menankoto, Dandoko, and Bakolobi properties. The Other Mineral Properties segment focuses on the company interests in mineral properties which are at various stages of exploration and evaluation. The Corporate and Other segment includes the corporate operations. The company was founded by Mark Anthony Corra, Thomas A. Garagan, Clive Thomas Johnson, and Roger Thomas Richer on November 30, 2006 and is headquartered in Vancouver, Canada.

B2gold Corp

B2Gold is trending following its recent earnings and 2026 guidance, sparking a polarized community debate where some investors see deep undervaluation amidst high gold prices, while others criticize management's execution and project outlook.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals is trending with its approved MASH drug, Rezdiffra, demonstrating strong market performance and leading to significant analyst upgrades, while the community actively discusses its blockbuster potential, aggressive pipeline expansion through new licensing deals, and the intensifying M&A environment in the MASH sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Prime Medicine, Inc. $PRME Shares Acquired by Alphabet Inc.

Alphabet Inc. increased its holdings in Prime Medicine, Inc. (NYSE:PRME - Free Report) by 10.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange...

Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates

Vanda (VNDA) delivered earnings and revenue surprises of +78.85% and -2.78%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Prime Medicine, Inc. (NYSE:PRME) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Prime Medicine, Inc. (NYSE:PRME - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seven ratings firms that are covering the firm, MarketBeat.com reports...

Prime Medicine (NYSE:PRME) Trading Down 5.5% - What's Next?

Prime Medicine (NYSE:PRME) Trading Down 5.5% - What's Next...

Prime Medicine (NASDAQ:PRME) Shares Down 5.6% - What's Next?

Prime Medicine (NASDAQ:PRME) Trading Down 5.6% - Here's Why...

Prime Medicine (NASDAQ:PRME) Shares Up 10.5% - Here's Why

Prime Medicine (NASDAQ:PRME) Trading 10.5% Higher - Here's Why...

Prime Medicine (NYSE:PRME) Shares Up 12.4% - Time to Buy?

Prime Medicine (NYSE:PRME) Stock Price Up 12.4% - Here's Why...

Sumitomo Mitsui Trust Group Inc. Boosts Stake in Prime Medicine, Inc. $PRME

Sumitomo Mitsui Trust Group Inc. boosted its holdings in Prime Medicine, Inc. (NYSE:PRME - Free Report) by 127.7% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The...

Prime Medicine (NASDAQ:PRME) Trading Down 7.9% - Should You Sell?

Prime Medicine (NASDAQ:PRME) Trading Down 7.9% - What's Next...

Prime Medicine (NYSE:PRME) Trading Down 5.7% - What's Next?

Prime Medicine (NYSE:PRME) Shares Down 5.7% - Here's What Happened...

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Prime Medicine Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $WMT earnings on Thursday?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.25	--	--	N/A
Q3 '25	-$0.25	-$0.32	-26.51%	MISSED
Q2 '25	-$0.35	-$0.41	-16.75%	MISSED
Q1 '25	-$0.31	-$0.40	-27.61%	MISSED
Q4 '24	-$0.34	-$0.31	8.35%	BEAT

PRME
Prime Medicine Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest PRME News

PRMEPrime Medicine Inc